Immunogenicity and Safety of an MF59-adjuvanted Quadrivalent Seasonal Influenza Vaccine in Young Children at High Risk of Influenza-associated Complications: A Phase III, Randomized, Observer-blind, Multicenter Clinical Trial
2020 ◽
Vol 39
(8)
◽
pp. e185-e191
◽
Keyword(s):
2019 ◽
Vol 85
◽
pp. S10-S17
◽
Keyword(s):
Keyword(s):
2019 ◽
Vol 85
◽
pp. S26-S38
◽
Keyword(s):
Keyword(s):